Literature DB >> 9813499

[Effect of intrathecal or intracerebroventricular administrition of OFQ on pain threshold and acpuncture analgesia in rats].

X L Zhang1, C B Zhu, S F Xu, X D Cao, G C Wu, M Y Li, D F Cui, C W Chi.   

Abstract

Orphanin FQ (OFQ) is a newly discovered 17-amino-acid peptide capable of inducing hyperalgesia. In the present study, the effects of OFQ on basal pain threshold and acupuncture anlgesia (AA) in rats were observed using the tail-flick test. It was found that intrathecal (i.t.) or intracerebroventricular (i.c.v.) administrition of 0.1 microgram OFQ had no effect on basal pain threshold of rats, while 1 microgram OFQ could lower the threshold. However, OFQ at both the doses (0.1 or 1.0 microgram) administered by either i.t. or i.c.v. injection could antagonize AA with that occuring in the brain being more prominent then in the spinal cord. When the rats were repeatedly treated with antisense oligonucleotide to block synthesis of OFQ receptor, pain threshold increased significantly. At such instance, when the OFQ was combined with acupuncture, the effect of AA showed no obvious change. The above results show that the OFQ at small dose has no effect on pain threshold but can lower it at larger dose; while in both cases OFQ can antagonize AA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9813499

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  2 in total

1.  Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.

Authors:  Xiaohong Chen; Ellen B Geller; Martin W Adler
Journal:  Eur J Pharmacol       Date:  2006-11-10       Impact factor: 4.432

2.  Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.

Authors:  Katarzyna Popiolek-Barczyk; Ewelina Rojewska; Agnieszka M Jurga; Wioletta Makuch; Ferenz Zador; Anna Borsodi; Anna Piotrowska; Barbara Przewlocka; Joanna Mika
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.